Ryan R. Craig - 02 Sep 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & Chief HR Officer
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
02 Sep 2025
Net transactions value
$0
Form type
4
Filing time
04 Sep 2025, 11:53:06 UTC
Previous filing
21 Nov 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Craig Ryan R EVP & Chief HR Officer 220 VIRGINIA AVEUNE, INDIANAPOLIS /s/ Kathleen S. Kiefer, Attorney in fact 04 Sep 2025 0002084547

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Award $0 +970 +22% $0.000000 5,353 02 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +3,690 $0.000000 3,690 02 Sep 2025 Common Stock 3,690 $322.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units. Restrictions lapse as follows: 323 shares each on 9/2/2026 and 9/2/2027, and 324 shares on 9/2/2028.
F2 The option represents a right to purchase a total of 3,690 shares, and is exercisable in three annual installments of 1,230 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date.